Psychiatry Addresses Long-Term Antidepressant Use Uncertainty
Case Western psychiatry professor Awais Aftab, writing in the New York Times and his newsletter, argues psychiatry should engage transparently with patients' concerns about long-term antidepressant and SSRI use. He outlines risks including withdrawal symptoms (dizziness, insomnia, "brain zaps") and psychological dependence, and urges clinician-supervised, gradual tapering while acknowledging dosing and protocol challenges. The piece highlights clinicians' frequent failure to address patient ambivalence and calls for informed, individualized decisions.
Key Points
- 1Highlights widespread patient ambivalence about long-term SSRI use and clinicians' limited engagement
- 2Explains tradeoffs and withdrawal risks, including dizziness, insomnia, "brain zaps", and possible protracted symptoms
- 3Advises slow, clinician-supervised tapering, noting dosing and protocol challenges for practical discontinuation
Scoring Rationale
Useful clinician-focused guidance and credible expert source, limited novelty and low relevance to data-science audience.
Sources
Public references used for this report.
Practice with real Health & Insurance data
90 SQL & Python problems · 15 industry datasets
250 free problems · No credit card
See all Health & Insurance problems
